NovoCure Limited (NVCR)

NASDAQ

$15.70

$+0.04

(+0.25%)

Regular Market

NovoCure Limited (NVCR) Live Price Chart

Last updated: ⁦2026-10-21 16:01:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

NovoCure Limited (NVCR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $15.70, with a market capitalization of $1.73B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.82 to $21.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.73B
Open	$15.60
Day's High	$232.76
Day's Low	$5.95
Previous Close	$15.71
Volume	900.22K
Average Volume	1.49M
P/E Ratio	--
52-Week High	$21.45
52-Week Low	$9.82
Dividend Yield	--
Earnings Date	--

NovoCure Limited (NVCR) Stock Price Today

NovoCure Limited (NVCR) is currently trading at $15.70 as of 2026-10-21 15:44:25, down 0.08% ($0.01) from the previous close of $15.71

During today's regular trading session, NVCR has traded between $5.95 and $232.76, with a trading volume of 900.22K shares. The current price is near the lower end of today's range.

NovoCure Limited (NVCR) 7-Day Stock Price Change

Over the past seven days, NovoCure Limited (NVCR) moved from $14.72 to $15.70, representing a gain of 6.64% ($0.98).

The stock traded between $13.76 and $16.13 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.40 million shares, down versus the previous seven-day period, indicating lower trading activity.

NVCR 52-Week Price Position

Position in Range: 50.5%

52W Low$9.82

52W High$21.45

NVCR is currently trading at $15.70, placing it 50.5% of the way from its 52-week low of $9.82 to its 52-week high of $21.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is NovoCure Limited (NVCR)?

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

NovoCure Limited Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	1605
Exchange	NASDAQ
Company Website	https://www.novocure.com

How to Buy NovoCure Limited (NVCR) Stock on MEXC

Eligible investors can buy real shares of NovoCure Limited (NVCR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NVCR and Place Your Order

Open the RealStocks trading page and search for NVCR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is NovoCure Limited (NVCR) stock price today?

NovoCure Limited (NVCR) is currently trading at $ 15.70, down 0.08% ($0.01) from the previous close of $ 15.71. Intraday prices update in real time during regular trading hours.

2.Is NVCR stock going up or down today?

As of 2026-10-21 15:44:25, NVCR is trading at $ 15.70, down 0.08% ($0.01) from its previous close of $ 15.71. The stock has traded between $ 5.95 and $ 232.76 during today’s regular session. Past price movements do not guarantee future results.

3.What is NVCR pre-market price?

As of 2026-10-21 15:44:25, NVCR is trading at $ 15.69 in pre-market trading, down 0.15% ($0.02) from the previous close of $ 15.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NVCR after-hours price?

As of 2026-10-21 15:44:25, NVCR is trading at $ 15.59 in after-hours trading, down 0.74% ($0.12) from the regular-session close of $ 15.71. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NVCR stock trading now?

NVCR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NVCR sit relative to its 52-week high and low?

Over the past 52 weeks, NVCR has traded between a low of $ 9.82 and a high of $ 21.45. At $ 15.70, the stock is positioned 50.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is NovoCure Limited in?

NovoCure Limited (NVCR) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is NovoCure Limited's market capitalization and where is it listed?

NovoCure Limited is listed on the NASDAQ exchange with a market capitalization of $ 1.73B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NVCR valued in terms of P/E ratio and EPS?

NVCR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does NovoCure Limited pay a dividend?

NovoCure Limited pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.